CJC-1295 (without DAC) and GHRP-2 Interaction

Synergistic

Researched 95% confidence

CJC-1295 (without DAC) and GHRP-2 have a synergistic interaction with 95% confidence. Potent combination maximizing GH through dual pathways. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss

ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic

View full profile

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Half-life: ~30 minutes Typical dose: 100-300 mcg growth hormone, weight loss

ghrelin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic

View full profile

Combined Organ Load

GI Tract

low

Pituitary

low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), GHRP-2). Monitor accordingly.

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), GHRP-2). Monitor fasting glucose and HbA1c.

2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), GHRP-2). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with GHRP-2?

Yes, CJC-1295 (without DAC) and GHRP-2 can generally be taken together. Potent combination maximizing GH through dual pathways.

Is CJC-1295 (without DAC) and GHRP-2 safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and GHRP-2?

Potent combination maximizing GH through dual pathways. This assessment has 95% confidence and is based on documented research data.

How should I time CJC-1295 (without DAC) and GHRP-2?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and GHRP-2 has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs GHRP-2

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.